Hdac3 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Hdac3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Histone Deacetylase 3 Protein | |
|---|---|
| Protein Name | Histone Deacetylase 3 |
| Gene | [HDAC3](/genes/hdac3) |
| UniProt ID | [O15379](https://www.uniprot.org/uniprot/O15379) |
| PDB Structure | 4A69, 4XBF, 5IX0 |
| Molecular Weight | 33 kDa |
| Subcellular Localization | Nucleus |
| Protein Family | Class I Histone Deacetylase |
HDAC3 is a 428-amino acid class I histone deacetylase. It contains a conserved catalytic domain with a zinc-binding motif (His-Asp-Asp-His). HDAC3 interacts with the NCoR and SMRT co-repressor complexes through its C-terminal region, which is essential for its deacetylase activity and recruitment to chromatin.
HDAC3 catalyzes the removal of acetyl groups from lysine residues on histones and non-histone proteins. As part of NCoR/SMRT complexes, HDAC3 represses gene expression involved in metabolism, inflammation, and circadian rhythm. In neurons, HDAC3 regulates synaptic plasticity, memory formation, and neuronal survival. Its activity is dynamically regulated by phosphorylation and interaction with co-repressor complexes.
| Disease | Mechanism | Evidence |
|---|---|---|
| Alzheimer's Disease | Dysregulated epigenetic control of memory and inflammatory genes. HDAC3 activity alters neuronal gene expression. | Post-mortem studies, animal models |
| Huntington's Disease | HDAC3 contributes to transcriptional dysregulation. HDAC3 inhibitors show therapeutic potential. | Mouse models |
| Multiple Sclerosis | Alters immune cell gene expression. | EAE models |
| Cancer | Overexpression in various cancers; HDAC3 inhibitors in clinical trials. | Clinical studies |
HDAC3 plays a critical role in regulating gene expression programs involved in synaptic plasticity, memory formation, and neuronal survival. In Alzheimer's disease, increased HDAC3 activity contributes to transcriptional dysregulation of memory-related genes. In Huntington's disease, HDAC3 inhibition restores brain-derived neurotrophic factor (BDNF) expression and improves motor function in mouse models.
Selective HDAC3 inhibitors such as RGFP966 have shown promise in pre-clinical models of Alzheimer's disease and Parkinson's disease, reducing neuroinflammation, improving synaptic integrity, and enhancing cognitive performance.
HDAC3 contributes to AD pathogenesis through:
HDAC3 functions within multi-protein repression complexes:
The balance between histone acetylation and deacetylation regulates gene expression. HDAC3-mediated deacetylation promotes heterochromatin formation and gene silencing. In neurodegeneration, this often leads to repression of neuroprotective genes and activation of pro-inflammatory pathways.